Study: Pfizer jab efficacy falls to 84% after 6 months

A recent study showed that the efficacy of the COVID-19 vaccine BNT162b2 developed by Pfizer and BioNTech fell from 96%, within two months of receiving it, to 84% six months after vaccination.

In a p…